New Onset Diabetes and Non-Alcoholic Fatty Liver Disease after Liver Transplantation

Journal Title: Annals of Hepatology - Year 2017, Vol 16, Issue 6

Abstract

Background & Aims. Non-alcoholic fatty liver disease (NAFLD) is an emerging cause of graft dysfunction after liver transplantation (LT) frequently related to the development of new onset diabetes after LT (NODAT). This study was undertaken to evaluate the frequencies of NODAT and NAFLD after LT, to investigate their major risk factors and the impact of de novo or recurrent NAFLD in graft function. Material and methods. 119 patients submitted to LT were prospectively evaluated. Results. After 4 ± 1 years, NODAT, recurrent and de novo NAFLD were observed in 31%, 56% and 43% of the subjects, respectively. Only 3 patients had non-alcoholic steatohepatitis (NASH) without fibrosis. Other risk factors for NAFLD such as arterial hypertension (AHT), metabolic syndrome (MS), hypertriglyceridemia and obesity were seen in 51%, 50%, 35% and 24% of the subjects, respectively. In addition, insulin resistance (IR), assessed by HOMA-IR and β-cell dysfunction, determined by HOMA-β, were observed in 16% and 94% of the patients, respectively. Occurrence of NODAT was associated with male gender, higher waist circumference, higher HOMA-IR and lower HOMA-β values. No correlation was found between NAFLD and NODAT, MS, hypertriglyceridemia, obesity and HOMAIR and HOMA-β levels. Conclusions. NODAT, recurrent and de novo NAFLD are common after LT but are not associated with signs of graft dysfunction, possibly due to the low frequency of IR and NASH. No correlation is observed between NAFLD and NODAT, MS, hypertriglyceridemia, obesity and IR. β-cell dysfunction and diabetes, however, are seen in most of the patients, possibly due to calcineurin inhibitor toxicity.

Authors and Affiliations

Antônio R. Andrade, Paulo L. Bittencourt, Liana Codes, Maria A. Evangelista, Alessandra O. Castro, Ney Boa Sorte, Carolina G Almeida, Jorge A. Bastos, Helma P. Cotrim

Keywords

Related Articles

Predictive role BLVRA mRNA expression in hepatocellular cancer

Introduction and aim. Hepatocellular carcinoma (HCC) is the most common primary malignant liver tumor. It is primarily causedby hepatic cirrhosis or chronic viral hepatitis. Hepatic carcinogenesis is associated with inc...

Synergistic Effect of Celecoxib on 5-fluorouracil-induced Apoptosis in Hepatocellular Carcinoma Patien

Background. Cyclooxygenase-2 (COX-2) enzyme over expression is reported in many human HCC cell line studies and is linked to tumor cell resistance to chemotherapy-induced apoptosis. We hypothesized that adding a COX-2 in...

Hepatic carcinosarcoma: clinicopathologic features and a review of the literature

Hepatic carcinosarcoma (HCS) is defined as a malignant tumor containing an intimate mixture of carcinomatous and sarcomatous elements. Here, we report the case of a 72-year-old man who developed HCS from an otherwise nor...

Liver transplantation for autoimmune hepatitis in Peru: outcomes and recurrence

Background. Liver transplantation is the only therapy for end-stage liver disease. Cirrhosis secondary to autoimmune hepatitis (AIH) is an indication in 4-6% of adult transplants. Aims. To describe the outcomes and recur...

Download PDF file
  • EP ID EP228009
  • DOI 10.5604/01.3001.0010.5285
  • Views 92
  • Downloads 0

How To Cite

Antônio R. Andrade, Paulo L. Bittencourt, Liana Codes, Maria A. Evangelista, Alessandra O. Castro, Ney Boa Sorte, Carolina G Almeida, Jorge A. Bastos, Helma P. Cotrim (2017). New Onset Diabetes and Non-Alcoholic Fatty Liver Disease after Liver Transplantation. Annals of Hepatology, 16(6), 932-940. https://europub.co.uk/articles/-A-228009